Company Filing History:
2 out of 549 
2 out of 1,584 
Years Active: 2019-2023
Title: Yifu Fang: Innovator in Cardiovascular and Bone Disorder Treatments
Introduction
Yifu Fang is a notable inventor based in St. Louis, MO (US), recognized for his contributions to the fields of cardiovascular disease and bone disorders. He holds 2 patents that focus on innovative treatment methods utilizing biomarker levels and receptor signaling inhibitors.
Latest Patents
Fang's latest patents include methods for treating cardiovascular diseases using ActRII ligand traps. These methods involve monitoring specific biomarkers, such as snail homolog 1 (Snai1) and dickkopf homolog 1 (Dkk1), to determine the responsiveness and efficacy of treatments. Additionally, he has developed methods for addressing bone resorption and disorders associated with kidney disease through the administration of Activin-ActRIIA inhibitors.
Career Highlights
Throughout his career, Yifu Fang has worked with prominent organizations, including Celgene Corporation and Washington University. His work has significantly advanced the understanding and treatment of complex medical conditions.
Collaborations
Fang has collaborated with esteemed colleagues, including William H. Smith and Victoria Sung, contributing to a rich exchange of ideas and innovations in his field.
Conclusion
Yifu Fang's innovative work in treating cardiovascular and bone disorders showcases his commitment to advancing medical science. His patents reflect a deep understanding of the underlying mechanisms of these diseases and offer promising avenues for future treatments.